(Q40604508)

22 September 2017

title

Pharmacokinetics of ceftazidime in febrile neutropenic patients (English)

1 reference

22 September 2017

1 reference

1 reference

Nyhlén A

1

1 reference

22 September 2017

Ljungberg B

series ordinal

2

1 reference

22 September 2017

Nilsson-Ehle I

series ordinal

3

1 reference

22 September 2017

publication date

1 January 2001

1 reference

Scandinavian Journal of Infectious Diseases

22 September 2017

published in

1 reference

22 September 2017

volume

33

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

222-226

1 reference

Advancing age and acute infection influence the kinetics of ceftazidime

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540151060941

Pharmacokinetics of meropenem in febrile neutropenic patients. Swedish study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540151060941

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540151060941

Influence of age on the pharmacokinetics of ceftazidime in acutely ill, adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540151060941

Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540151060941

Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540151060941

10.1080/00365540151060941

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference